MX2019011270A - Productos masticables en gel para ingredientes farmaceuticos activos. - Google Patents

Productos masticables en gel para ingredientes farmaceuticos activos.

Info

Publication number
MX2019011270A
MX2019011270A MX2019011270A MX2019011270A MX2019011270A MX 2019011270 A MX2019011270 A MX 2019011270A MX 2019011270 A MX2019011270 A MX 2019011270A MX 2019011270 A MX2019011270 A MX 2019011270A MX 2019011270 A MX2019011270 A MX 2019011270A
Authority
MX
Mexico
Prior art keywords
active pharmaceutical
pharmaceutical ingredients
chewable gel
gel products
chewable
Prior art date
Application number
MX2019011270A
Other languages
English (en)
Inventor
SIRIHORACHAI Rachan
D Bradley Reginald
D Rosar Paul
Ekpe Anthony
Original Assignee
Bayer Healthcare Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Llc filed Critical Bayer Healthcare Llc
Publication of MX2019011270A publication Critical patent/MX2019011270A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente divulgación se refiere a productos masticables en gel que contienen un portador en gel y un ingrediente farmacéutico activo (IFA), donde el producto masticable en gel tiene un sabor aceptable.
MX2019011270A 2017-03-20 2018-03-16 Productos masticables en gel para ingredientes farmaceuticos activos. MX2019011270A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762473763P 2017-03-20 2017-03-20
PCT/US2018/023003 WO2018175261A1 (en) 2017-03-20 2018-03-16 Chewable gel products for active pharmaceutical ingredients

Publications (1)

Publication Number Publication Date
MX2019011270A true MX2019011270A (es) 2019-10-24

Family

ID=63521393

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019011270A MX2019011270A (es) 2017-03-20 2018-03-16 Productos masticables en gel para ingredientes farmaceuticos activos.

Country Status (6)

Country Link
US (2) US20180263904A1 (es)
EP (1) EP3599892B1 (es)
AU (2) AU2018239993B2 (es)
CA (1) CA3057078A1 (es)
MX (1) MX2019011270A (es)
WO (1) WO2018175261A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2828509B2 (es) * 2019-11-26 2022-03-09 Fund Idonial Composicion para la impresion 3d de farmacos semisolidos
BR102022006848A2 (pt) * 2022-04-08 2023-10-24 Eurofarma Laboratorios S.A. Uso de prednisolona ou seus sais farmacêuticos ativos em uma composição farmacêutica, composição farmacêutica, seu processo de preparação e seu uso

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004019885A2 (en) 2002-08-29 2004-03-11 Linguagen Corp. Fast dissolving film delivery of nucleotides that inhibit the unpleasant taste of bitter tasting medications
US20070292501A1 (en) * 2006-06-05 2007-12-20 Udell Ronald G Chewable soft gelatin capsules
WO2008098195A2 (en) 2007-02-09 2008-08-14 Todd Maibach Film comprising nitroglycerin
US20080286340A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered nicotine containing products
CN101686931B (zh) 2007-06-06 2013-06-19 巴斯夫欧洲公司 用于制备可咀嚼片剂和锭剂的药物配制剂
GB0818473D0 (en) * 2008-10-08 2008-11-12 Probio Nutraceuticals As Composition
GB0918590D0 (en) 2009-10-22 2009-12-09 Ayanda As Composition
GB201016900D0 (en) * 2010-10-06 2010-11-17 Probio Asa Emulsion
JP6067676B2 (ja) 2011-04-11 2017-01-25 アヤンダ グループ エーエス 経口医薬分散組成物
PL2956011T3 (pl) * 2013-02-14 2018-09-28 Sanofi Kompozycja do żucia do podawania doustnego i sposób jej wytwarzania
US20160067180A1 (en) * 2014-09-05 2016-03-10 Santa Cruz Pharmaceuticals, Inc. Semi-solid chewable dosage form for over-the-counter medications and method for producing same
CN104490819A (zh) * 2014-12-05 2015-04-08 海南卫康制药(潜山)有限公司 一种氯雷他定组合物咀嚼片及其制备方法
CN107613789A (zh) 2015-04-07 2018-01-19 丘奇和德怀特有限公司 具有软核的多组分软糖组合物

Also Published As

Publication number Publication date
EP3599892A1 (en) 2020-02-05
EP3599892A4 (en) 2020-09-02
AU2024201751A1 (en) 2024-04-04
US20180263904A1 (en) 2018-09-20
US20220000771A1 (en) 2022-01-06
EP3599892B1 (en) 2024-04-03
AU2018239993B2 (en) 2024-01-25
EP3599892C0 (en) 2024-04-03
WO2018175261A1 (en) 2018-09-27
CA3057078A1 (en) 2018-09-27
AU2018239993A1 (en) 2019-10-10

Similar Documents

Publication Publication Date Title
EP4269440A3 (en) Composition for treating il-6-related diseases
AU2019268159A1 (en) Systems and methods for synthesizing chemical products, including active pharmaceutical ingredients
PH12017502376A1 (en) Oral solid formulation containing irinotecan and method of preparing the same
CR20220215A (es) Heteroaril bifenil amidas para el tratamiento de enfermedades relacionadas con el ligando pd-l1
NZ728401A (en) High purity oritavancin and method of producing same
AU2017262586A1 (en) Improved drug formulations
IL280376A (en) The history of boronic acid, its preparation and pharmaceutical preparations containing it
MX2020008761A (es) Productos alimenticios prebióticos en gomita.
IL272806B1 (en) The history of boronic acid, its preparation and pharmaceutical preparations containing it
MX2019010228A (es) Composición para liberación controlada de sustancias fisiológicamente activas y proceso para su preparación.
BR112017022523A2 (pt) ?formulação para cápsulas de gel, cápsula de gel, e, processo?.
MY183068A (en) Pharmaceutical formulation comprising antibody
MX2019011270A (es) Productos masticables en gel para ingredientes farmaceuticos activos.
AU2017370226A1 (en) Pharmaceutical composition containing insulin-like growth factor-2 and use thereof
EA201691741A1 (ru) Фармацевтическая композиция
MX2018010065A (es) Forma de dosificacion oral que comprende rifaximina en forma beta.
MX2022001772A (es) Formulaciones de isotretinoina y usos y metodos de las mismas.
MX2022013576A (es) Composicion para la liberacion controlada de sustancias fisiologicamente activas y proceso para su preparacion.
MX2019015869A (es) Nuevas formulaciones orales de belinostat.
AU2017256125A1 (en) Oral composition
WO2015126151A3 (ko) 신곡 추출물을 포함하는 상처 치료용 조성물
MX2020011170A (es) Derivados de 1-imidazotiadiazol-2h-pirrol-5-ona.
EP3833396A4 (en) DRUG DELIVERY PRODUCT, COMPOSITION AND SYSTEM
WO2019082221A3 (en) Device and method for oral administration of active principles
WO2019088707A3 (ko) 알룰로스를 포함하는 크림 조성물